Treatment of Ipilimumab Induced Graves’ Disease in a Patient with Metastatic Melanoma

Figure 1

Nodular hyperplasia of the thyroid (a) secondary to the patient’s Graves’ disease, demonstrating abundant follicular structures with scant colloid (b); high power view of patient’s papillary thyroid microcarcinoma demonstrating vesicular nuclei, nuclear grooves, and nuclear crowding (c); and representative discohesive, high grade malignant cells of the patient’s malignant melanoma requiring ipilimumab therapy (d).

(a)

(b)

(c)

(d)